Skip to main content
Erschienen in: World Journal of Surgery 2/2017

26.10.2016 | Original Scientific Report

Trends and Hospital Variations in Surgical Outcomes for Cholangiocarcinoma in New York State

verfasst von: Han Liu, Xi Cen, Tao Suo, Xueya Cai, Xuewen Yuan, Sheng Shen, Houbao Liu, Yue Li

Erschienen in: World Journal of Surgery | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

This population-based study examined surgical outcomes and hospital and post-acute care resource use after operations of cholangiocarcinoma during 2005–2012.

Study design

Using New York State hospital claims, we identified subjects with intrahepatic tumor who underwent hepatectomy only (n = 2089), subjects with perihilar tumor who underwent hepatectomy and biliary-enteric anastomosis (BEA; n = 389) or BEA only (n = 3721), and subjects with distal cholangiocarcinoma undergoing pancreatectomy or pancreaticoduodenectomy (n = 228). We performed trend analyses for each group and calculated overall risk-adjusted mortality, complication, and 30-day readmission rates for hospitals using multivariable logistic regressions.

Results

Mortality rate was roughly 12 % over years for perihilar cases undergoing hepatectomy and BEA, significantly higher than the rates of other 3 groups (p = 0.000). The overall complication rate was 40 % for subjects undergoing both hepatectomy and BEA, more than doubling the rate for subjects undergoing hepatectomy or BEA alone (p = 0.000). Average LOS declined markedly for perihilar cases undergoing hepatectomy and BEA (from 21 days in 2005 to 16 days in 2012) and subjects with distal cholangiocarcinoma (from 22 days in 2005 to 16 days in 2012), but other outcomes did not change dramatically. Risk-adjusted hospital outcome rates varied substantially.

Conclusions

Surgical patients with cholangiocarcinoma incur considerable mortality, postoperative complications, and resource uses, especially among those undergoing hepatectomy and BEA for perihilar tumors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Vauthey JN, Blumgart LH (1994) Recent advances in the management of cholangiocarcinoma. Semin Liver Dis 14(2):109–114CrossRefPubMed Vauthey JN, Blumgart LH (1994) Recent advances in the management of cholangiocarcinoma. Semin Liver Dis 14(2):109–114CrossRefPubMed
2.
Zurück zum Zitat Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366(9493):1303–1314CrossRefPubMed Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366(9493):1303–1314CrossRefPubMed
3.
Zurück zum Zitat Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM (2014) Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr 3(1):18–34PubMedPubMedCentral Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM (2014) Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr 3(1):18–34PubMedPubMedCentral
4.
Zurück zum Zitat Endo I, Gonen M, Yopp AC et al (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248(1):84–96CrossRefPubMed Endo I, Gonen M, Yopp AC et al (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248(1):84–96CrossRefPubMed
5.
Zurück zum Zitat DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245(5):755–762CrossRefPubMedPubMedCentral DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245(5):755–762CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Bhardwaj N, Garcea G, Dennison AR, Maddern GJ (2015) The surgical management of Klatskin tumours: has anything changed in the last decade? World J Surg 39(11):2748–2756CrossRefPubMed Bhardwaj N, Garcea G, Dennison AR, Maddern GJ (2015) The surgical management of Klatskin tumours: has anything changed in the last decade? World J Surg 39(11):2748–2756CrossRefPubMed
7.
Zurück zum Zitat Lang H, Sotiropoulos GC, Sgourakis G et al (2009) Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208(2):218–228CrossRefPubMed Lang H, Sotiropoulos GC, Sgourakis G et al (2009) Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208(2):218–228CrossRefPubMed
8.
Zurück zum Zitat Yubin L, Chihua F, Zhixiang J et al (2008) Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China. Ann Surg Oncol 15(8):2113–2119CrossRefPubMed Yubin L, Chihua F, Zhixiang J et al (2008) Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China. Ann Surg Oncol 15(8):2113–2119CrossRefPubMed
9.
Zurück zum Zitat Nuzzo G, Giuliante F, Ardito F et al (2012) Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 147(1):26–34CrossRefPubMed Nuzzo G, Giuliante F, Ardito F et al (2012) Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 147(1):26–34CrossRefPubMed
10.
Zurück zum Zitat Ribero D, Pinna AD, Guglielmi A et al (2012) Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg 147(12):1107–1113CrossRefPubMed Ribero D, Pinna AD, Guglielmi A et al (2012) Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg 147(12):1107–1113CrossRefPubMed
11.
Zurück zum Zitat Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD (2007) Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointestinal Surg 11(11):1488–1496; discussion 1496–1487 Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD (2007) Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointestinal Surg 11(11):1488–1496; discussion 1496–1487
12.
Zurück zum Zitat Loehrer AP, House MG, Nakeeb A, Kilbane EM, Pitt HA (2013) Cholangiocarcinoma: are North American surgical outcomes optimal? J Am Coll Surg 216(2):192–200CrossRefPubMed Loehrer AP, House MG, Nakeeb A, Kilbane EM, Pitt HA (2013) Cholangiocarcinoma: are North American surgical outcomes optimal? J Am Coll Surg 216(2):192–200CrossRefPubMed
14.
Zurück zum Zitat Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36(1):8–27CrossRefPubMed Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36(1):8–27CrossRefPubMed
15.
Zurück zum Zitat Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130–1139CrossRefPubMed Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130–1139CrossRefPubMed
17.
Zurück zum Zitat Nakeeb A, Pitt HA, Sohn TA, et al. (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224(4):463–473; discussion 473–465 Nakeeb A, Pitt HA, Sohn TA, et al. (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224(4):463–473; discussion 473–465
19.
Zurück zum Zitat Glance LG, Li Y, Osler TM, Mukamel DB, Dick AW (2008) Impact of the present-on-admission code in administrative data on patient safety measurement in patients undergoing CABG: experience with the AHRQ patient safety indicators. BMC Health Serv Res 8(1):176CrossRefPubMedPubMedCentral Glance LG, Li Y, Osler TM, Mukamel DB, Dick AW (2008) Impact of the present-on-admission code in administrative data on patient safety measurement in patients undergoing CABG: experience with the AHRQ patient safety indicators. BMC Health Serv Res 8(1):176CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Osborne NH, Nicholas LH, Ryan AM, Thumma JR, Dimick JB (2015) Association of hospital participation in a quality reporting program with surgical outcomes and expenditures for medicare beneficiaries. JAMA 313(5):496–504CrossRefPubMedPubMedCentral Osborne NH, Nicholas LH, Ryan AM, Thumma JR, Dimick JB (2015) Association of hospital participation in a quality reporting program with surgical outcomes and expenditures for medicare beneficiaries. JAMA 313(5):496–504CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Glance LG, Osler T, Li Y et al (2016) Outcomes are worse in US patients undergoing surgery on weekends compared with weekdays. Med Care 54(6):608–615CrossRefPubMed Glance LG, Osler T, Li Y et al (2016) Outcomes are worse in US patients undergoing surgery on weekends compared with weekdays. Med Care 54(6):608–615CrossRefPubMed
22.
Zurück zum Zitat Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O (2006) SAS for mixed models, 2nd edn. SAS Institute Inc., Cary Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O (2006) SAS for mixed models, 2nd edn. SAS Institute Inc., Cary
23.
Zurück zum Zitat Iezzoni LI (2012) Risk adjustment for measuring health care outcomes, vol 3. Health Administration Press, Chicago Iezzoni LI (2012) Risk adjustment for measuring health care outcomes, vol 3. Health Administration Press, Chicago
24.
Zurück zum Zitat Li Y, Dick AW, Glance LG, Cai X, Mukamel DB (2007) Misspecification issues in risk adjustment and construction of outcome-based quality indicators. Health Serv Outcomes Res Method 7(1–2):39–56CrossRef Li Y, Dick AW, Glance LG, Cai X, Mukamel DB (2007) Misspecification issues in risk adjustment and construction of outcome-based quality indicators. Health Serv Outcomes Res Method 7(1–2):39–56CrossRef
25.
Zurück zum Zitat Cram P, Lu X, Kaboli PJ et al (2011) Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991–2008. JAMA 305(15):1560–1567CrossRefPubMedPubMedCentral Cram P, Lu X, Kaboli PJ et al (2011) Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991–2008. JAMA 305(15):1560–1567CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Ryan J, Linde-Zwirble W, Engelhart L, Cooper L, Cohen DJ (2009) Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program. Circulation 119(7):952–961CrossRefPubMed Ryan J, Linde-Zwirble W, Engelhart L, Cooper L, Cohen DJ (2009) Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program. Circulation 119(7):952–961CrossRefPubMed
27.
Zurück zum Zitat Bueno H, Ross JS, Wang Y et al (2010) Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA 303(21):2141–2147CrossRefPubMedPubMedCentral Bueno H, Ross JS, Wang Y et al (2010) Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA 303(21):2141–2147CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat James J (2013) Health policy brief: medicare hospital readmissions reduction program. Health affairs James J (2013) Health policy brief: medicare hospital readmissions reduction program. Health affairs
29.
Zurück zum Zitat McGarry BE, Blankley AA, Li Y (2016) The impact of the medicare hospital readmission reduction program in New York state. Med Care 54(2):162–171CrossRefPubMed McGarry BE, Blankley AA, Li Y (2016) The impact of the medicare hospital readmission reduction program in New York state. Med Care 54(2):162–171CrossRefPubMed
30.
Zurück zum Zitat Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI (2000) Identification of in-hospital complications from claims data. Is it valid? Med Care 38(8):785–795CrossRefPubMed Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI (2000) Identification of in-hospital complications from claims data. Is it valid? Med Care 38(8):785–795CrossRefPubMed
31.
Zurück zum Zitat Houchens RL, Elixhauser A, Romano PS (2008) How often are potential patient safety events present on admission? Jt Comm J Qual Patient Saf/Jt Comm Res 34(3):154–163 Houchens RL, Elixhauser A, Romano PS (2008) How often are potential patient safety events present on admission? Jt Comm J Qual Patient Saf/Jt Comm Res 34(3):154–163
32.
Zurück zum Zitat Coffey R, Milenkovic M, Andrews R (2006) The case for the Present-on-Admission (POA) indicator. Rockville Coffey R, Milenkovic M, Andrews R (2006) The case for the Present-on-Admission (POA) indicator. Rockville
33.
Zurück zum Zitat Kassed C, Kowlessar N, Pfunter, A, Parlato J, Andrews, RM (2011) The case for the POA indicator: update, 2011. Rockville Kassed C, Kowlessar N, Pfunter, A, Parlato J, Andrews, RM (2011) The case for the POA indicator: update, 2011. Rockville
Metadaten
Titel
Trends and Hospital Variations in Surgical Outcomes for Cholangiocarcinoma in New York State
verfasst von
Han Liu
Xi Cen
Tao Suo
Xueya Cai
Xuewen Yuan
Sheng Shen
Houbao Liu
Yue Li
Publikationsdatum
26.10.2016
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 2/2017
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3733-5

Weitere Artikel der Ausgabe 2/2017

World Journal of Surgery 2/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.